Article ID Journal Published Year Pages File Type
8227828 International Journal of Radiation Oncology*Biology*Physics 2012 10 Pages PDF
Abstract
Reirradiation with bevacizumab is a feasible and effective treatment for patients with recurrent high-grade gliomas. A randomized trial is warranted to finally answer the question whether bevacizumab adds substantial benefit to a radiotherapeutic retreatment setting.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Irradiation and Bevacizumab in High-Grade Glioma Retreatment Settings
Authors
, , , , , , , , , , , , , , ,